MEMPHASYS |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.008 AUD | 0.00% |
|
+14.29% | -33.33% |
| 06-06 | Memphasys Acting CEO Transitions to Permanent Role | MT |
| 05-30 | Memphasys Appoints Consultant to Help Develop Animal Breeding Devices | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MEMPHASYS | Other Biotechnology & Medical Research | 0.00% | +14.29% | - | - | - | 0 | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- MEM Stock
- Charts Memphasys
- Comparison Chart
